Access to Medication for Opioid Use Disorder Faces Critical Barriers in U.S. Jails and During Natural Disasters
Key Finding: A study covering over 3,000 U.S. jails found that fewer than half offered any access to medication for opioid use disorder (OUD), despite federal data showing up to one in four national overdose deaths involved individuals recently released from incarceration.
Treatment Access in U.S. Correctional Facilities
National and State Findings
A comprehensive study of over 3,000 U.S. jails revealed that fewer than half provided any access to OUD medication. Experts attribute this gap to a lack of specialized providers and concerns about medication diversion, with some suggesting injectable formulations as a potential solution.
Federal data from 2021 indicated that up to one in four national overdose deaths involved individuals recently released from incarceration. A National Institutes of Health study further found that individuals were up to 40 times more likely to die from overdoses in the weeks following prison release compared to the general population.
Alaska Department of Corrections Policy
In Alaska, a patient identified as H. was receiving a monthly buprenorphine shot for OUD and anticipated a treatment interruption due to an upcoming incarceration. The Alaska Department of Corrections (DOC) confirmed it provides OUD medication for a maximum of 30 days, primarily for individuals already receiving it, with an exception for pregnant individuals. The DOC stated plans to pilot a more comprehensive program by February 2026.
Community clinics, such as the Ninilchik Community Clinic on the Kenai Peninsula, provide care for individuals with OUD before and after incarceration but cannot assist those inside correctional facilities.
Rhode Island Program Outcomes
Rhode Island introduced a comprehensive OUD treatment program for all eligible individuals in its DOC care in 2016. Within one year, the state observed a 61% reduction in overdose death rates among recently incarcerated individuals and a 12% reduction statewide. The program's developer, Dr. Jennifer Clarke, noted that treatment improved inmate participation in therapy but faced funding, logistical, and stigma-related challenges.
Hurricane Helene's Disruption of OUD Medication Access in North Carolina
Specific Case and Emergency Measures
Toni Brewer, an Asheville resident in recovery for 18 months, had three days of Suboxone remaining after evacuating to Franklin, NC. She obtained a refill through the Mountain Area Health Education Center patient portal and picked it up in Clayton, GA, paying $130 out-of-pocket.
The Substance Abuse and Mental Health Services Administration (SAMHSA) worked with states to ensure access, and North Carolina approved emergency measures for treatment flexibility.
Regulatory and Infrastructure Factors
- Methadone is only obtainable through in-person visits to federally controlled opioid treatment centers, many of which closed after the storm.
- Buprenorphine is regulated by the DEA's suspicious orders report system, which restricted supply during the emergency without exceptions, according to clinical director Blake Fagan.
- Some pharmacies limited refills to three days, assuming patients would return home.
Expert and Patient Statements
Dr. Elizabeth Cerceo, climate health director at Rowan University's Cooper Medical School: "When people are displaced or unable to get to their usual clinics or pharmacies, those challenges just become insurmountable."
Dr. Cordelia Stearns, chief medical officer at High Country Community Health: "The things that my patients did to be able to access their bupe... it was astonishing."
Toni Brewer: "It's terrifying just to have that feeling again of, 'I need this, and I'll do whatever it takes to get this.'"